Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 12681-12690 Newer>

The Motley Fool February 27, 2006 Rich Smith	Foolish Forecast: BJ's Delivers Thanks to a 20% run-up in share price over the past three months, BJ's shares are starting to look pricey. The company has some work to do if it's to grow into its valuation.
The Motley Fool February 27, 2006 Rich Smith	Foolish Forecast: Autodesk Opens Its Drawers Autodesk sports a premium multiple even after the recent share price weakness: 30 times trailing earnings.
The Motley Fool February 27, 2006 Seth Jayson	FARO Flops Again Unfortunately, investors who didn't heed FARO's safe-harbor warnings last quarter are licking their wounds again this week, after FARO's latest swing in the biff-your-own-earnings-projections derby.
The Motley Fool February 27, 2006 Rich Smith	1,001 Teutonic Nights, Part 4 Investors, get to know Germany: Fresenius Medical Care... Altana... Schering...
The Motley Fool February 27, 2006 Rick Aristotle Munarriz	Ask, the World Turns Ask.com starts a new life with Jeeves riding off into the sunset. But losing the edge of Jeeves won't matter if the company is able to put its many dot-com puzzle pieces together. Investors, take note.
The Motley Fool February 27, 2006 Rick Aristotle Munarriz	4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Here's a closer look at four of the companies that inched their payouts higher this past week: Sherwin-Williams... Rocky Mountain Chocolate Factory... etc.
The Motley Fool February 27, 2006	Brokerages and Minimums Look around, and you can find some low- or no-minimum brokerages.
BusinessWeek March 6, 2006 Gene G. Marcial	RIM: Back From The Edge Some Wall Street pros contend RIM is unlikely to be shutting down its BlackBerry operations.
BusinessWeek March 6, 2006 Gene G. Marcial	Why Glaxo Looks More Robust Big pharma, besieged by generic rivals, is hardly a Street favorite. But GlaxoSmithKline may be an exception.
BusinessWeek March 6, 2006 Gene G. Marcial	Zonagen Is Feeling Its Oats Investors buying into tiny Zonagen, whose shares have more than doubled since August, include some big players.
<Older 12681-12690 Newer> Return to current articles.